Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
USP36–Snail1 Axis in Ribotoxic Stress
2026-09-07
The reference study identifies a JNK–USP36–Snail1 surveillance axis that allows solid tumor cells to preserve nucleolar ribosome biogenesis during ribotoxic stress. Its findings explain why homoharringtonine can be effective in leukemia yet less active against solid tumors, and support combination strategies that disable this adaptive response.
-
SGC-CBP30: A Mechanistic Lens on LUAD Enhancers
2026-09-05
SGC-CBP30 offers a precise way to examine CREBBP and EP300 bromodomain function within transcriptional and super-enhancer networks. This article translates lung adenocarcinoma findings into practical assay decisions while distinguishing established evidence from testable mechanistic hypotheses.
-
Temafloxacin: From Target Biology to Assay Design
2026-09-04
Temafloxacin is a fluoroquinolone broad-spectrum antibacterial agent whose value depends on matching concentration, pathogen biology, and endpoint selection. This guide connects its mechanism and assay specifications with a fermentation-engineering study to develop a more rigorous framework for reproducible antibacterial research.
-
U 46619: Mapping TP Signals to Renal Biology
2026-09-04
U 46619 is a defined TP-receptor agonist for resolving platelet and vascular phenotypes across concentration and time. This article connects its signaling logic with renal ischemia-reperfusion research while showing how to avoid confusing hemodynamic effects with ferroptosis-specific mechanisms.
-
AhR Mediates MEHP Toxicity in Ovarian Follicles
2026-09-03
The reference study identifies aryl hydrocarbon receptor activation as a functional mediator of mono(2-ethylhexyl) phthalate toxicity in mouse ovarian antral follicles. Pharmacological AhR blockade partially restores follicle growth, estrogen production, and estrogen-responsive gene expression, providing a mechanistic framework for environmental toxicology research.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-09-03
FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin conjugate for detecting accessible α-D-glucose and α-D-mannose residues on glycoproteins and glycolipids in cells or tissues. It is suited to immunofluorescence staining and flow cytometry carbohydrate detection, but it should not be treated as a general protein-binding probe or used outside its defined storage and stability conditions.
-
Anlotinib: Reframing Anti-Angiogenic TKI Research
2026-09-02
Anlotinib hydrochloride offers a translationally useful way to connect VEGFR2, PDGFRβ, and FGFR1 inhibition with endothelial phenotypes and tumor-angiogenesis biology. This thought-leadership guide explains how to interpret the evidence, design more informative assays, and move beyond product-page descriptions toward mechanism-led cancer research.
-
DiD Membrane Labeling for ROS Assays
2026-09-02
DiD and DiDC 18 (5) provide a red fluorescent membrane readout that can complement mechanistic studies of ROS-driven macrophage inflammation. This guide develops an assay framework for membrane integrity, cell tracking, and immunofluorescence while clearly separating membrane signals from mitochondrial and inflammasome endpoints.
-
CRTC–CREB Senses Proteotoxic Stress in Drosophila
2026-09-01
The reference study identifies CRTC–CREB as a stress-responsive transcriptional system activated by proteasome inhibition through ROS and JNK. Using Drosophila, cultured cells, transcriptomics, and a Huntington’s disease model, it shows that enhancing this pathway can improve proteostasis and reduce protein aggregation, while also defining important limits for translation to oncology and neurodegeneration research.
-
EDTA-Free Protease Inhibitor Cocktail K4002
2026-09-01
The Protease Inhibitor Cocktail is a 100X, DMSO-based EDTA-Free Protease Inhibitor for broad protection of proteins during cell and tissue extraction. Its multi-component design supports protein stability in Western blotting, immunoprecipitation, imaging, and kinase workflows, while the cited OXPHOS study provides biological context rather than direct product validation.
-
Fra2/LCN2 Links PM2.5 to Asthma Ferroptosis
2026-08-31
A 2026 Redox Biology study identifies Fra2-driven LCN2 activation as a mechanistic link between PM2.5 exposure, impaired mitophagy, and ferroptosis in M2 macrophages during asthma aggravation. Genetic LCN2 suppression reduced airway inflammation and improved lung function in mice, providing a framework for studying pollution-associated asthma through macrophage iron and redox biology.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-31
FITC-Concanavalin A is a fluorescent lectin conjugate for visualizing α-D-glucose and α-D-mannose residues associated with glycoproteins and glycolipids. It is appropriate for cell surface carbohydrate detection, immunofluorescence staining, and flow cytometry, but it should not be used as a universal glycan stain or as a probe for non-carbohydrate targets.
-
Kitasamycin for Swine Dysentery: Evidence and Limits
2026-08-30
This study tested kitasamycin against Australian Brachyspira hyodysenteriae isolates and in experimentally infected pigs, linking isolate-level susceptibility with prevention and treatment outcomes. Its central practical finding is that kitasamycin controlled swine dysentery caused by a susceptible isolate, while widespread macrolide resistance limits broad therapeutic generalization.
-
Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor
2026-08-29
Z-LEHD-FMK is an irreversible caspase-9 inhibitor for dissecting mitochondria-mediated apoptosis. Its reported use spans apoptosis assays, TRAIL-rescue experiments, cancer research, and preclinical neuroprotection workflows.
-
Alternariol (AOH) Workflow for Fibrosis Research
2026-08-28
Build a controlled AOH workflow that connects chemical exposure to LX-2 activation, apoptosis, cytochrome P450 biology, and detoxification testing. This practical guide separates literature-supported mechanisms from starting conditions for dose finding, phenotype validation, and troubleshooting.